Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru

Cohn, 1997, Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD global surveillance project, Clin Infect Dis, 24, S121, 10.1093/clinids/24.Supplement_1.S121 Musser, 1995, Antimicrobial agent resistance in mycobacteria: molecular genetic insights, Clin Microbiol Rev, 8, 496, 10.1128/CMR.8.4.496 Ramaswamy, S, Musser, J, M, Molecular genetic base of antimicrobin/agent resistance in Mycobacterium tuberculosis: 1998 update, Tuberc Lung Dis Scorpio, 1996, Mutations in pncA , a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus, Nature Med, 2, 662, 10.1038/nm0696-662 Sreevatsan, 1997, Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms, Antimicrob Agents Chemother, 41, 636, 10.1128/AAC.41.3.636 Scorpio, 1997, Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis, Antimicrob Agents Chemother, 41, 540, 10.1128/AAC.41.3.540 Hirano, 1998, Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis, Tuberc Lung Dis, 78, 117, 10.1016/S0962-8479(98)80004-X Telenti, 1997, The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol, Nature Med, 3, 567, 10.1038/nm0597-567 Sreevatsan, 1997, Ethambutol resistance in Mycobacterium tuberculosis : critical role of embB mutations, Antimicrob Agents Chemother, 41, 1677, 10.1128/AAC.41.8.1677 Rinder, 1997, Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone, Microbial Drug Resist, 3, 195, 10.1089/mdr.1997.3.195 Wayne, 1974, Simple pyrazinamidase and urease tests for routine identification of mycobacteria, Am Rev Respir Dis, 109, 147 Canetti, 1969, Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity test in tuberculosis control programs, Bull WHO, 41, 21 Vareldzis, 1994, Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations, Tuberc Lung Dis, 75, 1, 10.1016/0962-8479(94)90096-5 van Embden, 1993, Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology, J Clin Microbiol, 31, 406, 10.1128/JCM.31.2.406-409.1993 Groenen, 1993, Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis : application for strain differentiation by a novel typing method, Mol Microbiol, 10, 1057, 10.1111/j.1365-2958.1993.tb00976.x Goyal, 1997, Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS 6110 restriction fragment length polymorphism, J Clin Microbiol, 35, 647, 10.1128/JCM.35.3.647-651.1997 Kapur, 1995, Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing, Arch Pathol Lab Med, 119, 131 Musser, 1996, Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance, J Infect Dis, 173, 196, 10.1093/infdis/173.1.196 Sreevatsan, 1997, Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination, Proc Natl Acad Sci USA, 94, 9869, 10.1073/pnas.94.18.9869 Telenti, 1993, Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis, Lancet, 341, 647, 10.1016/0140-6736(93)90417-F Takiff, 1994, Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations, Antimicrob Agents Chemother, 38, 773, 10.1128/AAC.38.4.773 Kurepina, 1998, Characteristics of the phylogenetic distribution and chromosomal insertion sites of five IS 6110 elements inMycobacterium tuberculosis : nonrandom integration in the dnaA-dnaN region, Tuberc Lung Dis van Soolingen, 1995, Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia, J Clin Microbiol, 33, 3234, 10.1128/JCM.33.12.3234-3238.1995 Lee, 1997, Lack of clinical significance for the common arginine-to-leucine substitution at codon 463 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis in Singapore, J Infect Dis, 176, 1125, 10.1086/517320 Musser, 1997, Reply, J Infect Dis, 176, 1126, 10.1086/517321 Hermans, 1995, Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and the Netherlands: usefulness of DNA typing for global tuberculosis epidemiology, J Infect Dis, 171, 1504, 10.1093/infdis/171.6.1504 Edlin, 1992, An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome, N Engl J Med, 326, 1514, 10.1056/NEJM199206043262302 Frieden, 1996, A multi-institutional outbreak of highly drug-resistant tuberculosis. Epidemiology and clinical outcomes, JAMA, 276, 1229, 10.1001/jama.1996.03540150031027 Bifani, 1996, Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family: adverse implications for tuberculosis control in the 21st century, JAMA, 275, 452, 10.1001/jama.1996.03530300036037 Ritacco, 1997, Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires, J Infect Dis, 176, 637, 10.1086/514084 Blazquez, 1997, Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients, J Clin Microbiol, 35, 1390, 10.1128/JCM.35.6.1390-1393.1997 Wengenack, 1997, Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid, J Infect Dis, 176, 722, 10.1086/514096 Pablos-Mendez, 1998, Global surveillance for antituberculosis-drug resistance, 1994–1997, N Engl J Med, 338, 1641, 10.1056/NEJM199806043382301 Vasquez, 1997, Vigilancia de la resistencia a los medicamentos antituberculosos en el Peru, 1995–1996, Rev Med Exp INS, 14, 5 Casper, 1996, The transcontinental transmission of tuberculosis: a molecular epidemiological assessment, Am J Public Health, 86, 551, 10.2105/AJPH.86.4.551 Yang, 1998, Diversity of DNA fingerprints of Mycobacterium tuberculosis isolates in the United States, J Clin Microbiol, 36, 1003, 10.1128/JCM.36.4.1003-1007.1998 Agerton, 1997, Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis . Community outbreak and nosocomial transmission via a contaminated bronchoscope, JAMA, 278, 1073, 10.1001/jama.1997.03550130047035 De Beenhouwer, 1995, Rapid detection of rifampin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay, Tubercle Lung Dis, 76, 425, 10.1016/0962-8479(95)90009-8 Rossau, 1997, Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection ofMycobacterium tuberculosis complex and its resistance to rifampin, Antimicrob Agents Chemother, 41, 2093, 10.1128/AAC.41.10.2093 Nash, 1997, Detection of rifampin resistance in Mycobacterium tuberculosis by use of a rapid, simple, and specific RNA/RNA mismatch assay, J Infect Dis, 176, 533, 10.1086/517283 Pai, 1997, Routine rapid Mycobacterium species assignment based on species-specific allelic variation in the 65-kilodalton heat shock protein gene (hsp65), Arch Path Lab Med, 121, 859 Telenti, 1997, Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis : a blind study at reference laboratory level, J Clin Microbiol, 35, 719, 10.1128/JCM.35.3.719-723.1997